Apeloa Pharmaceutical Co

Apeloa Pharmaceutical Co Goodwill

The Goodwill of Apeloa Pharmaceutical Co (000739.SZ) as of Oct 21, 2026 is 20.31 M CNY. In the previous year, Goodwill was 20.31 M CNY — a change of 0.00% (lower).

Goodwill

20.31 MCNY

YoY

0.00%

Last updated:

Goodwill of Apeloa Pharmaceutical Co is 2025 20.31 M CNY. Goodwill of Apeloa Pharmaceutical Co was 2024 20.31 M CNY. It decreases by 0.00% lower compared to the previous year.

The Apeloa Pharmaceutical Co Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2018
29.50 M CNY
Jan 1, 2019
20.31 M CNY
Jan 1, 2020
20.31 M CNY
Jan 1, 2021
20.31 M CNY
Jan 1, 2022
20.31 M CNY
Jan 1, 2023
20.31 M CNY
Jan 1, 2024
20.31 M CNY
Jan 1, 2025
20.31 M CNY
The Apeloa Pharmaceutical Co Goodwill history
YEARGoodwillYoY
20.31 MCNY0.00%
20.31 MCNY0.00%
20.31 MCNY0.00%
20.31 MCNY0.00%
20.31 MCNY0.00%
20.31 MCNY0.00%
20.31 MCNY-31.16%
29.50 MCNY0.00%
29.50 MCNY0.00%
29.50 MCNY0.00%
29.50 MCNY0.00%
29.50 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Apeloa Pharmaceutical Co Stock analysis

What does Apeloa Pharmaceutical Co do? Apeloa Pharmaceutical Co., Ltd. generates revenue through the research, development, and production of active pharmaceutical ingredient (API) intermediates, contract development and production services (CDMO), and preparations. The company’s main products include bulk drugs, intermediates, chemical preparations, and Chinese traditional medicine preparations such as ubenimex capsules, cefixime, and amantadine. These products are sold to both domestic and overseas markets, with the company distributing its offerings across these segments. The firm’s business model focuses on serving pharmaceutical manufacturers and healthcare providers through its comprehensive range of API intermediates and finished preparations. The company’s revenue streams are derived from the sale of bulk drugs, intermediates, and chemical preparations, alongside its Chinese traditional medicine preparations like ubenimex capsules and cefixime. These products are targeted at pharmaceutical manufacturers seeking API intermediates and finished drug formulations. Apeloa Pharmaceutical serves both domestic and international clients, with its products distributed in both markets. The company’s CDMO services further support clients in the development and production of pharmaceutical products. Apeloa Pharmaceutical’s core business involves the production and sale of API intermediates, bulk drugs, and various preparations, including traditional Chinese medicine products. The company’s main customers are pharmaceutical manufacturers and healthcare providers who require intermediates for drug manufacturing and finished preparations for market distribution. Its domestic and overseas market presence ensures a diversified revenue base, with products like ubenimex capsules and amantadine contributing to its product portfolio. Apeloa Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apeloa Pharmaceutical Co stock

Goodwill of Apeloa Pharmaceutical Co is 20.31 M CNY in 2025.

Goodwill of Apeloa Pharmaceutical Co changed from 20.31 M CNY to 20.31 M CNY, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill Apeloa Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Apeloa Pharmaceutical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Apeloa Pharmaceutical Co

All Key Metrics — Apeloa Pharmaceutical Co